Mendra

About Mendra

Mendra is a venture-backed biopharma company focused on rare and ultra-rare diseases, accelerating the development and commercialization of de-risked breakthrough therapies through AI-enabled approaches. The company partners with R&D-stage biotech firms to advance therapies by handling regulatory, clinical, and reimbursement strategy, with a patient-centered focus on families affected by these conditions. Their leadership combines deep experience in rare disease development, strategic partnerships, and commercial execution to bring treatments to market more efficiently. Based in the biopharma ecosystem, Mendra emphasizes collaborations with academic researchers, biotech startups, and patient foundations to fund, license, and commercialize therapies for underserved patient populations.